December 10, 2024 - 17:31

The Federal Trade Commission (FTC) is intensifying its scrutiny of the artificial intelligence (AI) sector, focusing on concerns regarding excessive hype and insufficient competition. As AI technologies continue to proliferate across various industries, regulators are increasingly wary of the potential monopolistic tendencies that may arise. The FTC's investigation aims to ensure that consumers benefit from genuine innovation rather than inflated claims that may mislead the public.
With the upcoming elections, the implications of this scrutiny could extend into the political arena, particularly if former President Trump returns to power. His administration had previously shown interest in deregulating tech industries, which could complicate the FTC's efforts to maintain a competitive landscape. As the AI industry evolves, the balance between fostering innovation and preventing monopolistic practices will be a critical focus for regulators. The outcome of these investigations could shape the future of AI development and its role in the economy.
June 21, 2026 - 01:52
Mankind must not sacrifice human dignity at the altar of AISome ways of talking about human beings are always out of bounds. Sorting people by economic value into those who merit work and those who should be sidelined is one of them, and any society that...
June 20, 2026 - 18:23
Is Marvell Technology Going to $1 Trillion?Nvidia`s chief executive recently made a bold prediction about Marvell Technology, suggesting the chipmaker could one day join the trillion-dollar club. The comment sparked fresh interest in a...
June 19, 2026 - 18:29
A Tech Twist for Father's Day: New App Brings Old Photos to LifeForget the usual tie or toolbox this Father`s Day. A new mobile application is offering a different kind of gift: the chance to see faded memories with fresh eyes. The app uses simple artificial...
June 19, 2026 - 00:54
FDA panel backs first-of-its-kind flu vaccine using mRNA technologyA new kind of flu vaccine moved a step closer to the U.S. market Thursday. An advisory panel for the Food and Drug Administration voted overwhelmingly in favor of approving the first influenza shot...